Boosting Your Brain Power
Cerluten is a peptide bioregulator specifically harnessed to boost and protect the central nervous system.
Benefits of Cerluten peptide bioregulator
- Works alongside the central nervous system to restore and re-energize itself
- Protects and helps restore vital processes of the central nervous system
- Serves the same role as peptide bioregulators developed naturally in the body
- No adverse side effects
The importance of a healthy central nervous system
Cerluten supports the central nervous system, which communicates between the brain and the internal organs. Diseases of the nervous system can be painful, crippling, and potentially fatal. Their likelihood increases as we age, due to the natural depletion of crucial electrolytes and enzymes.
What is a peptide bioregulator
A peptide is a short chain of amino acids, identified by the fact that it is shorter than a protein, and so can be absorbed easily via the digestive system. Each organ or bodily function has its own unique peptide bioregulator.
Peptide bioregulators have been shown to shortcut the protein synthesis process by interacting directly with cell DNA – meaning that organs can build and repair tissues easier and quicker when peptide bioregulators are active.
Professor Vladimir Khavinson's approach to aging
Peptide bioregulators were first discovered in the 1980s by professor Vladimir Khavinson, a doctor working on behalf of the Kremlin to devise palliative care medicines for army veterans.
He noticed that in healthy individuals with all their bodily faculties working at optimum performance, the level of peptide bioregulators in each of their organs was exactly 42%.
New Russian peptide revolution
Decades of testing fostered a "new Russian peptide revolution", as it was revealed that supplementing peptide bioregulators with synthetically created natural analogues yielded no adverse side effects, yet served the same role as those developed organically in the body, which decrease as we age. Hence, a remarkable new range of supplements has entered the market.